Mirum Pharmaceuticals, Inc. (MIRM)
98.06
+0.60
(+0.62%)
USD |
NASDAQ |
Aug 31, 16:00
98.00
-0.06
(-0.06%)
After-Hours: 17:20
Mirum Pharmaceuticals Cash from Operations (Annual) : 55.83M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 55.83M |
| December 31, 2024 | 10.32M |
| December 31, 2023 | -70.94M |
| December 31, 2022 | -120.14M |
| Date | Value |
|---|---|
| December 31, 2021 | -132.76M |
| December 31, 2020 | -89.08M |
| December 31, 2019 | -39.36M |
| December 31, 2018 | -0.373M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Incyte Corp. | 1.413B |
| Insmed, Inc. | -935.01M |
| Praxis Precision Medicines, Inc. | -249.07M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |